The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N2-((1S,2S)-2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine ID: ALA4080283
PubChem CID: 60034150
Max Phase: Preclinical
Molecular Formula: C19H24ClN7
Molecular Weight: 385.90
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21
Standard InChI: InChI=1S/C19H24ClN7/c1-2-27-11-22-16-17(23-13-7-5-6-12(20)10-13)25-19(26-18(16)27)24-15-9-4-3-8-14(15)21/h5-7,10-11,14-15H,2-4,8-9,21H2,1H3,(H2,23,24,25,26)/t14-,15-/m0/s1
Standard InChI Key: UTBSBSOBZHXMHI-GJZGRUSLSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
17.1967 -3.5081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1956 -4.3276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9036 -4.7366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9019 -3.0992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6105 -3.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6107 -4.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3937 -4.5819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8774 -3.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3933 -3.2500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6464 -5.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0998 -5.9664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8994 -2.2821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1905 -1.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1914 -1.0591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4833 -0.6527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7758 -1.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7809 -1.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4896 -2.2876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0759 -2.2981 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.4876 -4.7357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7802 -4.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7802 -3.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0769 -3.0961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3665 -3.5006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3639 -4.3188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0717 -4.7324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0682 -5.5496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
4 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
2 20 1 0
21 20 1 6
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.90Molecular Weight (Monoisotopic): 385.1782AlogP: 3.93#Rotatable Bonds: 5Polar Surface Area: 93.68Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.91CX LogP: 3.69CX LogD: 1.29Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.62Np Likeness Score: -1.21
References 1. Shi Y, Park J, Lagisetti C, Zhou W, Sambucetti LC, Webb TR.. (2017) A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore., 27 (3): [PMID:28049589 ] [10.1016/j.bmcl.2016.12.056 ]